​

HealthEquity (HQY) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HQY Stock Forecast

HealthEquity (HQY) stock forecast, based on 27 Wall Street analysts, predicts a 12-month average price target of $107.33, with a high of $125.00 and a low of $89.00. This represents a 12.61% increase from the last price of $95.31.

$65 $77 $89 $101 $113 $125 High: $125 Avg: $107.33 Low: $89 Last Closed Price: $95.31

HQY Stock Rating

HealthEquity stock's rating consensus is Buy, based on 27 Wall Street analysts. The breakdown includes 1 Strong Buy (3.70%), 24 Buy (88.89%), 1 Hold (3.70%), 1 Sell (3.70%), and 0 Strong Sell (0.00%).

Buy
Total 27 1 1 24 1 Strong Sell Sell Hold Buy Strong Buy

HQY Price Target Upside V Benchmarks

TypeNameUpside
StockHealthEquity12.61%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 10.23%

Price Target Trends

1M3M12M
# Anlaysts-316
Avg Price Target-$108.00$110.88
Last Closing Price$95.31$95.31$95.31
Upside/Downside-13.31%16.34%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26510-1-16
Jun, 26510-1-16
May, 2659-1-15
Apr, 265811-15
Mar, 265911-16
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 03, 2026RBC Capital$108.00$88.3422.25%13.31%
Jun 01, 2026Wells Fargo$111.00$87.9926.15%16.46%
Apr 09, 2026Sean DodgeBMO Capital$105.00$84.2024.70%10.17%
Feb 24, 2026BMO Capital$85.00$74.7813.67%-10.82%
Feb 19, 2026Jefferies$108.00$78.7737.11%13.31%
Feb 18, 2026Peter WarendorfBarclays$110.00$74.3647.93%15.41%
Feb 17, 2026UBS$110.00$73.8848.89%15.41%
Feb 17, 2026Raymond James$100.00$73.8835.35%4.92%
Jan 09, 2026Goldman Sachs$89.00$98.51-9.65%-6.62%
Jan 08, 2026Scott SchoenhausKeyBanc$125.00$97.7727.85%31.15%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 03, 2026RBC CapitalOutperformOutperformhold
Jun 01, 2026CitigroupOutperformOutperformhold
Jun 01, 2026CitigroupMarket OutperformMarket Outperformhold
May 26, 2026KeyBancOverweightOverweighthold
Apr 09, 2026BMO CapitalMarket PerformOutperformupgrade
Mar 18, 2026BMO CapitalMarket PerformMarket Performhold
Feb 18, 2026BarclaysOverweightOverweighthold
Jan 09, 2026Goldman SachsNeutralSelldowngrade
Jan 08, 2026KeyBancOverweightOverweighthold
Dec 08, 2025BarclaysOutperformOverweightinitialise

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 $5 $6 Jan 22 Jan 23 Jan 24 Jan 25 Jan 26 Jan 27 Jan 28
Jan 22Jan 23Jan 24Jan 25Jan 26Jan 27Jan 28
Reported$-0.53$-0.31$0.65$1.11$2.50--
Avg Forecast$1.33$1.33$2.20$3.15$3.71$4.52$5.45
High Forecast$1.35$1.41$2.25$3.16$3.97$5.69$5.76
Low Forecast$1.31$1.31$2.13$3.12$3.63$3.45$5.35
Surprise %-139.85%-123.31%-70.45%-64.76%-32.61%--

Revenue Forecast

$500M $800M $1B $1B $2B $2B Jan 22 Jan 23 Jan 24 Jan 25 Jan 26 Jan 27 Jan 28
Jan 22Jan 23Jan 24Jan 25Jan 26Jan 27Jan 28
Reported$756.56M$861.75M$999.59M$1.20B$1.31B--
Avg Forecast$753.12M$858.80M$995.66M$1.19B$1.30B$1.44B$1.73B
High Forecast$762.24M$896.39M$999.18M$1.20B$1.38B$1.45B$1.80B
Low Forecast$742.03M$847.24M$992.71M$1.18B$1.28B$1.44B$1.70B
Surprise %0.46%0.34%0.39%0.51%1.07%--

Net Income Forecast

$-50M $70M $190M $310M $430M $550M Jan 22 Jan 23 Jan 24 Jan 25 Jan 26 Jan 27 Jan 28
Jan 22Jan 23Jan 24Jan 25Jan 26Jan 27Jan 28
Reported$-44.29M$-26.14M$55.71M$96.70M$215.20M--
Avg Forecast$-6.21M$115.98M$29.14M$94.29M$330.09M$397.45M$473.92M
High Forecast$-2.93M$122.58M$34.97M$95.50M$344.82M$494.96M$500.88M
Low Forecast$-9.50M$113.95M$23.31M$93.09M$315.36M$299.95M$465.62M
Surprise %612.72%-122.54%91.19%2.56%-34.81%--

HQY Forecast FAQ

Is HealthEquity stock a buy?

HealthEquity stock has a consensus rating of Buy, based on 27 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 24 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that HealthEquity is a favorable investment for most analysts.

What is HealthEquity's price target?

HealthEquity's price target, set by 27 Wall Street analysts, averages $107.33 over the next 12 months. The price target range spans from $89 at the low end to $125 at the high end, suggesting a potential 12.61% change from the previous closing price of $95.31.

How does HealthEquity stock forecast compare to its benchmarks?

HealthEquity's stock forecast shows a 12.61% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare information services stocks industry (10.23%).

What is the breakdown of analyst ratings for HealthEquity over the past three months?

  • July 2026: 31.25% Strong Buy, 62.50% Buy, 0% Hold, 6.25% Sell, 0% Strong Sell.
  • June 2026: 31.25% Strong Buy, 62.50% Buy, 0% Hold, 6.25% Sell, 0% Strong Sell.
  • May 2026: 33.33% Strong Buy, 60.00% Buy, 0% Hold, 6.67% Sell, 0% Strong Sell.

What is HealthEquity’s EPS forecast?

HealthEquity's average annual EPS forecast for its fiscal year ending in January 2027 is $4.52, marking a 80.80% increase from the reported $2.5 in 2026. Estimates for the following years are.

What is HealthEquity’s revenue forecast?

HealthEquity's average annual revenue forecast for its fiscal year ending in January 2027 is $1.44B, reflecting a 9.86% increase from the reported $1.31B in 2026. The forecast for.

What is HealthEquity’s net income forecast?

HealthEquity's net income forecast for the fiscal year ending in January 2027 stands at $397.45M, representing an 84.69% increase from the reported $215.2M in 2026. Projections indicate .